International Congress of Virology
国际病毒学大会
基本信息
- 批准号:8712920
- 负责人:
- 金额:$ 0.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-06-01 至 2015-05-31
- 项目状态:已结题
- 来源:
- 关键词:AnimalsAntiviral AgentsAntiviral resistanceAreaBacteriologyBiochemical GeneticsBiologyCapsidCellsCellular biologyCollaborationsCommunitiesCongressesDeveloping CountriesDevelopmentDisciplineDiseaseEcologyEducational workshopEnzymesFeesFosteringFundingGoalsHost DefenseHumanImmune responseIndustryInfectionInterdisciplinary StudyInternationalInternational AspectsJointsLeadMalignant NeoplasmsMeasuresMicrobiologyOrganismParticipantPathogenesisPlantsPostdoctoral FellowPreventionPrevention therapyQuebecRequest for ApplicationsResearchResearch PersonnelScientistSeminalSocietiesStructureSystemThe science of MycologyTherapeutic UsesTrainingTransgenesTravelVaccinesViralVirusVirus DiseasesWorkabstractingbasecareercombatgene therapygenetic analysisgraduate studenthuman diseasemeetingsmolecular assembly/self assemblyneglectpathogenplanetary Atmosphereplant growth/developmentposterspreventprogramspublic health relevancesymposiumtransmission processvirologyvirus host interactionvirus infection mechanism
项目摘要
DESCRIPTION (provided by applicant): The International Congress of Virology (ICV) is the premier international meeting in the field of virology. The conference covers all aspects of virus infection, including cell entry, replication, and assembly, the molecular basis of pathogenesis, and prevention and therapy. The 16th ICV will be held in Montreal, Quebec from July 28 to August 1, 2014 and feature plenary sessions, concurrent workshops, and poster sessions. Plenary speakers will present cutting-edge findings about the dynamic interactions of viruses with infected cells and organisms as well as host counter-measures to combat infection. Workshop conveners, chosen for their expertise in the topics covered in each session, will lead lively and open discussions following each presentation. Workshop presentations will be chosen from abstracts submitted for the poster sessions. Selections will be made to highlight exciting new developments in virus research with an emphasis on younger scientists, including new investigators, postdoctoral fellows, and graduate students. The poster sessions are an important and prominent aspect of the ICV, providing yet another opportunity for participants to present and discuss their research. Meeting participants will include well-known established investigators who have made seminal contributions to the field, young investigators launching independent research careers, postdoctoral fellows and graduate students, and investigators from industry, all drawn from a diverse, international community. The ICV will be held in conjunction with the International Congress of Bacteriology and Applied Microbiology and International Congress of Mycology and thus offer a unique opportunity for interactions across the broad discipline of microbiology. Daily bridging sessions, including a symposium of Nobel laureates, will bring together attendees of all three meetings. Funding is requested to provide partial support for conference fees and travel and lodging expenses for selected participants, in particular for young investigators who have been invited as plenary speakers, as well as for promising new investigators, postdoctoral fellows, graduate students, and investigators from developing nations who will present talks in the concurrent workshops. The impact of this meeting will come in promoting the free exchange of new findings and ideas in virology and fostering new scientific collaborations among investigators throughout the world.
描述(由申请人提供):国际病毒学大会(ICV)是病毒学领域的首要国际会议。会议涵盖了病毒感染的各个方面,包括细胞进入、复制和组装、发病机制的分子基础以及预防和治疗。第16届ICV将于2014年7月28日至8月1日在魁北克省蒙特利尔举行,包括全体会议、同期研讨会和海报会议。全体会议发言人将介绍有关病毒与受感染细胞和生物体动态相互作用的前沿发现,以及抗击感染的对策。研讨会召集人是根据每场会议所涵盖主题的专业知识而选出的,他们将在每次演讲后主持热烈和公开的讨论。研讨会的演讲将从提交海报会议的摘要中选出。评选将突出病毒研究领域令人兴奋的新进展,重点关注年轻科学家,包括新研究人员、博士后研究员和研究生。海报会议是 ICV 的一个重要且突出的方面,为参与者提供了另一个展示和讨论他们的研究的机会。会议参与者将包括对该领域做出了开创性贡献的知名研究人员、开展独立研究生涯的年轻研究人员、博士后研究员和研究生以及来自工业界的研究人员,所有这些都来自多元化的国际社会。 ICV 将与国际细菌学和应用微生物学大会以及国际真菌学大会同时举行,从而为微生物学广泛学科的互动提供了独特的机会。每日的桥接会议,包括诺贝尔奖获得者研讨会,将把所有三场会议的与会者聚集在一起。请求资金为选定的参与者,特别是被邀请作为全体会议发言人的年轻研究人员,以及有前途的新研究人员、博士后研究员、研究生和来自发展中国家的研究人员,提供部分会议费以及差旅费和住宿费的支持。将在同期研讨会上发表演讲的国家。这次会议的影响将促进病毒学新发现和想法的自由交流,并促进世界各地研究人员之间新的科学合作。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TERENCE S. DERMODY其他文献
TERENCE S. DERMODY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TERENCE S. DERMODY', 18)}}的其他基金
相似国自然基金
基于激发植物免疫为导向的嘧啶酮类高效抗病毒剂设计合成及作用机制研究
- 批准号:21807037
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
云南地方晾晒烟中的内源性抗烟草花叶病毒活性成分研究
- 批准号:31860100
- 批准年份:2018
- 资助金额:41.0 万元
- 项目类别:地区科学基金项目
两种植物中抗烟草花叶病毒先导化合物的结构优化、构效关系及作用机制研究
- 批准号:31760089
- 批准年份:2017
- 资助金额:38.0 万元
- 项目类别:地区科学基金项目
基于kealiinine类海洋生物碱的新型抗病毒剂的设计合成、构效关系及作用机制研究
- 批准号:21772145
- 批准年份:2017
- 资助金额:64.0 万元
- 项目类别:面上项目
生态农药的分子设计与作用机制
- 批准号:21732002
- 批准年份:2017
- 资助金额:300.0 万元
- 项目类别:重点项目
相似海外基金
Optimization of orally bioavailable inhibitors for the treatment of COVID-19 and other human coronavirus infections
用于治疗 COVID-19 和其他人类冠状病毒感染的口服生物可利用抑制剂的优化
- 批准号:
10698831 - 财政年份:2023
- 资助金额:
$ 0.5万 - 项目类别:
Development of sustained release/long acting products for TB
开发结核病缓释/长效产品
- 批准号:
10882260 - 财政年份:2023
- 资助金额:
$ 0.5万 - 项目类别:
IND-Enabling Development of a Small Molecule COVID Therapeutic
IND 促进小分子新冠肺炎治疗药物的开发
- 批准号:
10697173 - 财政年份:2023
- 资助金额:
$ 0.5万 - 项目类别:
Molecularly Engineered Lectins for Intranasal Prophylaxis and Treatment of Coronaviruses
用于鼻内预防和治疗冠状病毒的分子工程凝集素
- 批准号:
10629566 - 财政年份:2023
- 资助金额:
$ 0.5万 - 项目类别: